Expansion of myeloid-Derived suppressor cells in patients with acute coronary syndrome

Cellular Physiology and Biochemistry

Volumn 35, Issue 1, 2015, Pages 292-304

  Wang, Yan Ge ^a   Xiong, Xin ^a   Chen, Zhu Yue ^a   Liu, Kan Ling ^a   Yang, Jin Hua ^a   Wen, Qiang ^a   Wu, Fang Qin ^a   Hu, Xiao Fan ^a   Peng, Yu Dong ^a   Wu, Jing Jing ^a   Lian, Yi Tian ^a   Zhang, Wen Cai ^a,b   Cheng, Long Xian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Atherosclerosis; Inflammation; Myeloid derived suppressor cells

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ARGINASE 1; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD14 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA INTERFERON; HLA DR ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 6; NITRIC ACID DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ARGINASE; ARGINASE I, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; MESSENGER RNA;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BONE MARROW CELL; CELL EXPANSION; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MYELOID DERIVED SUPPRESSOR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STABLE ANGINA PECTORIS; SUPPRESSOR CELL; T LYMPHOCYTE; BLOOD; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; ELECTROCARDIOGRAPHY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY;

ACUTE CORONARY SYNDROME; ANGINA, STABLE; ANTIGENS, CD14; ARGINASE; CELL PROLIFERATION; CELLS, CULTURED; ELECTROCARDIOGRAPHY; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYELOID CELLS; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921325158     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369696     Document Type: Article

References (50)

1. Ross R: Atherosclerosis-An inflammatory disease. N Engl J Med 1999;340:115-126.
2. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
3. Hansson GK: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002;91:281-291.
4. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ: Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation 2002;105:1158-1161.
5. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW: Reduced atherosclerosis in myd88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004;10:416-421.
6. Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, Bariety J, Nicoletti A: In vivo downregulation of t helper cell 1 immune responses reduces atherogenesis in apolipoprotein e-knockout mice. Circulation 2001;104:197-202.
7. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK: Cytokine expression in adVanced human atherosclerotic plaques: Dominance of pro-inflammatory (th1) and macrophage-stimulating cytokines. Atherosclerosis 1999;145:33-43.
8. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH: The th17/treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008;127:89-97.
9. Zhang WC, Wang J, Shu YW, Tang TT, Zhu ZF, Xia N, Nie SF, Liu J, Zhou SF, Li JJ, Xiao H, Yuan J, Liao MY, Cheng LX, Liao YH, Cheng X: Impaired thymic export and increased apoptosis account for regulatory t cell defects in patients with non-st segment elevation acute coronary syndrome. J Biol Chem 2012;287:34157-34166
10. Young MR, Newby M, Wepsic HT: Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic lewis lung carcinoma tumors. Cancer Res 1987;47:100-105.
11. Gabrilovich DI, Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-174.
12. Greten TF, Manns MP, Korangy F: Myeloid derived suppressor cells in human diseases. Int Immunopharmacol 2011;11:802-807.
13. Cai W, Qin A, Guo P, Yan D, Hu F, Yang Q, Xu M, Fu Y, Zhou J, Tang X: Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis c patients. J Clin Immunol 2013;33:798-808.
14. Marhaba R, Vitacolonna M, Hildebrand D, Baniyash M, Freyschmidt-Paul P, Zoller M: The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J Immunol 2007;179:5071-5081.
15. Sun HL, Zhou X, Xue YF, Wang K, Shen YF, Mao JJ, Guo HF, Miao ZN: Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma. World J Gastroenterol 2012;18:3303-3309.
16. Youn JI, Gabrilovich DI: The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010;40:2969-2975.
17. Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S: Myeloid-derived suppressor cells inhibit t-cell activation by depleting cystine and cysteine. Cancer Res 2010;70:68-77.
18. Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI: Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 2009;182:5693-5701.
19. Loercher AE, Nash MA, KaVanagh JJ, Platsoucas CD, Freedman RS: Identification of an il-10-producing hla-dr-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous t cells. J Immunol 1999;163:6251-6260.
20. MacDonald KP, Rowe V, Clouston AD, Welply JK, Kuns RD, Ferrara JL, Thomas R, Hill GR: Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through il-10-producing regulatory t cells. J Immunol 2005;174:1841-1850.
21. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, Manns MP, Greten TF, Korangy F: A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces cd4(+) cd25(+)foxp3(+) t cells. Gastroenterology 2008;135:234-243.
22. Yi H, Guo C, Yu X, Zuo D, Wang XY: Mouse cd11b+gr-1+ myeloid cells can promote th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol 2012;189:4295-4304.
23. Poschke I, Kiessling R: On the armament and appearances of human myeloid-derived suppressor cells. Clin Immunol 2012;144:250-268.
24. Filipazzi P, Huber V, Rivoltini L: Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother 2012;61:255-263.
25. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V: Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010;22:238-244.
26. Janols H, Bergenfelz C, Allaoui R, Larsson AM, Ryden L, Bjornsson S, Janciauskiene S, Wullt M, Bredberg A, Leandersson K: A high frequency of mdscs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol 2014;96:685-693.
27. Poschke I, Mougiakakos D, Hansson J, Masucci GV, Kiessling R: Immature immunosuppressive cd14+hla-dr-/low cells in melanoma patients are stat3hi and overexpress cd80, cd83, and dc-sign. Cancer Res 2010;70:4335-4345.
28. Gordon IO, Freedman RS: Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients. Clin Cancer Res 2006;12:1515-1524.
29. Haile LA, von Wasielewski R, Gamrekelashvili J, Kruger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F, Greten TF: Myeloid-derived suppressor cells in inflammatory bowel disease: A new immunoregulatory pathway. Gastroenterology 2008;135:871-881, 881 e871-875.
30. Jiao Z, Hua S, Wang W, Wang H, Gao J, Wang X: Increased circulating myeloid-derived suppressor cells correlated negatively with th17 cells in patients with rheumatoid arthritis. Scand J Rheumatol 2013;42:85-90.
31. Yeager ME, Nguyen CM, Belchenko DD, Colvin KL, Takatsuki S, Ivy DD, Stenmark KR: Circulating myeloid-derived suppressor cells are increased and activated in pulmonary hypertension. Chest 2012;141:944-952.
32. Baumgart DC, Metzke D, Schmitz J, Scheffold A, Sturm A, Wiedenmann B, Dignass AU: Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005;54:228-236.
33. Duffy A, Zhao F, Haile L, Gamrekelashvili J, FioraVanti S, Ma C, Kapanadze T, Compton K, Figg WD, Greten TF: Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies. Cancer Immunol Immunother 2013;62:299-307.
34. Huang A, Zhang B, Wang B, Zhang F, Fan KX, Guo YJ: Increased cd14(+)hla-dr (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunol Immunother 2013;62:1439-1451.
35. Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ: Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 2009;58:49-59.
36. Tang H, Zhong Y, Zhu Y, Zhao F, Cui X, Wang Z: Low responder t cell susceptibility to the suppressive function of regulatory t cells in patients with dilated cardiomyopathy. Heart 2010;96:765-771.
37. Tang TT, Ding YJ, Liao YH, Yu X, Xiao H, Xie JJ, Yuan J, Zhou ZH, Liao MY, Yao R, Cheng Y, Cheng X: Defective circulating cd4cd25+foxp3+cd127(low) regulatory t-cells in patients with chronic heart failure. Cell Physiol Biochem 2010;25:451-458.
38. Meng K, Zhang W, Zhong Y, Mao X, Lin Y, Huang Y, Lang M, Peng Y, Zhu Z, Liu Y, Zhao X, Yu K, Wu B, Ji Q, Zeng Q: Impairment of circulating cd4cd25(+)garp(+) regulatory t cells in patients with acute coronary syndrome. Cell Physiol Biochem 2014;33:621-632.
39. Thakar M, Patil R, Shukre S, Bichare S, Kadam P, Khopkar P, Ghate M, Paranjape R: Genital tumor growth factor-beta1 levels in hiv-infected indian women are associated with reduced levels of innate antimicrobial products and increased hiv shedding. AIDS Res Hum Retroviruses 2014;30:648-653.
40. Di Luigi L, Sottili M, Antinozzi C, Vannelli GB, Romanelli F, Riccieri V, Valesini G, Lenzi A, Crescioli C: The vitamin d receptor agonist bxl-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies. PloS one 2013;8:e77745.
41. Niccoli G, Liuzzo G, Montone RA, Crea F: AdVances in mechanisms, imaging and management of the unstable plaque. Atherosclerosis 2014;233:467-477.
42. Galkina E, Ley K: Immune and inflammatory mechanisms of atherosclerosis (). Annu Rev Immunol 2009;27:165-197.
43. Sprague AH, Khalil RA: Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009;78:539-552.
44. Tedgui A, Mallat Z: Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev 2006;86:515-581.
45. Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, Geilich M, Winkels G, Traggiai E, Casati A, Grassi F, Bronte V: Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol 2010;40:22-35.
46. Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, Wang Z, Lang M, Stolz DB, Zheng XX, Demetris AJ, Liew FY, Wood KJ, Thomson AW: Il-33 expands suppressive cd11b+ gr-1(int) and regulatory t cells, including st2l+ foxp3+ cells, and mediates regulatory t cell-dependent promotion of cardiac allograft survival. J Immunol 2011;187:4598-4610.
47. Serafini P, Mgebroff S, Noonan K, Borrello I: Myeloid-derived suppressor cells promote cross-tolerance in b-cell lymphoma by expanding regulatory t cells. Cancer Res 2008;68:5439-5449.
48. Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, Hanke NT, Kartchner J, Janikashvili N, Bonnotte B, Larmonier N, Katsanis E: Myeloid-derived suppressor cells from tumor-bearing mice impair tgf-beta-induced differentiation of cd4+cd25+foxp3+ tregs from CD4+CD25-Foxp3-T cells. J Leukoc Biol 2012;92:987-997.
49. Nefedova Y, Nagaraj S, Rosenbauer A, Muro-Cacho C, Sebti SM, Gabrilovich DI: Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-Activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res 2005;65:9525-9535.
50. Huang JR, Tsai YC, Chang YJ, Wu JC, Hung JT, Lin KH, Wong CH, Yu AL: Alpha-galactosylceramide but not phenyl-glycolipids induced nkt cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3. J Immunol 2014;192:1972-1981.